The purpose is to give your body time to adapt at each stage before the dose goes higher
Microdosing semaglutide, typically at doses of 0.1 to 0.5 mg per week, has gained attention for researchers who want milder appetite effects, metabolic benefits without dramatic weight loss, or a more conservative approach
Joo E, Harada N, Yamane S et al (2017) Inhibition of gastric inhibitory polypeptide receptor signaling in adipose tissue reduces insulin resistance and hepatic steatosis in high-fat dietfed mice
Gala GLP-1 operates with transparent pricing and does not require insurance for any treatment program
In contrast, GLP-1 therapies were not associated with altered risk of Parkinsons disease, mild cognitive impairment and intracerebral hemorrhage versus other antidiabetic agents
They work by mimicking the GLP-1 hormone in the body that controls insulin and blood glucose levels, and their effects on the brain can reduce hunger, helping people feel full for longer